Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1190 Category:

The market for transdermal drug delivery systems is expected to hit USD 7.67 billion by 2024, growing over the forecast period at a CAGR of 4.33%. Factors such as the increase in the prevalence of chronic diseases and technological advances in transdermal drug delivery systems drive the growth of this market.

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 1

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 2

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 3

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 4

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 5

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 6

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 7

Transdermal Drug Delivery System Market by Applications (Central Nervous System Disorders, Pain Management, Cardiovascular Diseases, Hormonal Applications), by Type (Semisolid and Patches formulations), End User, and Region - 2019 to 2024 8

1 Global Transdermal Drug Delivery System Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Transdermal Drug Delivery System Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Transdermal Drug Delivery System Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Transdermal Drug Delivery System Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Transdermal Drug Delivery System Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Transdermal Drug Delivery System Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Transdermal Drug Delivery System Market – By Type (Market Size – & million/billion)
8.1 Transdermal Patches
8.2 Transdermal Semisolids

9 Global Transdermal Drug Delivery System Market – By Applications
9.1 Pain Management
9.2 Hormonal Applications
9.3 Central Nervous System Disorders
9.4 Cardiovascular Diseases
9.5 Other

10 Global Transdermal Drug Delivery System Market – By End-User
10.1 Home Care Settings
10.2 Hospitals & Clinics

11 Global Transdermal Drug Delivery System Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Transdermal Drug Delivery System Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Transdermal Drug Delivery System Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Hisamitsu Pharmaceutical Co., Inc.
13.3 Mylan N.V.
13.4 UCB S.A.
13.5 Novartis AG
13.6 Purdue Pharma L.P.
13.7 Lavipharm
13.8 Glaxosmithkline PLC
13.9 Johnson & Johnson (J&J)
13.10 Endo International, Inc.
13.11 Boehringer Ingelheim International GmbH
13.12 Company 11 & more

14 Global Transdermal Drug Delivery System Market – Appendix
14.1 Sources
14.2 Abbreviations